Antifungal effects and potential mechanism of bortezomib in combination with fluconazole against Candida albicans
Yuting Wang, Bing Wang, Jinfeng Li, Shuqing Ma, Peng Liu, Zhitao Teng, Haijie Zou, Rinan Cong, Xiaojing Sui, Xiaohui Li, Yingjie Cui · 2026
Read Antifungal effects and potential mechanism of bortezomib in combination with fluconazole against Candida albicans by Yuting Wang, Bing Wang, Jinfeng Li, Shuqing Ma, Peng Liu, Zhitao Teng, Haijie Zou, Rinan Cong, Xiaojing Sui, Xiaohui Li, Yingjie Cui (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627029.txt.
Description
Yuting Wang and co-authors test a drug pair against the yeast Candida albicans in this 2026 paper. The yeast causes common fungal infections, and resistance to the standard drug fluconazole is growing. Few treatment choices exist. The team paired fluconazole with bortezomib, a cancer drug that blocks protein cleanup in cells.
The pair was tested on free floating yeast and on biofilms. Against resistant strains the two drugs worked far better together than alone. The dose needed for each drug dropped sharply in the pair. The effect also held for strains that were still sensitive to fluconazole. The authors probe how the pair kills the yeast. Repurposing a known drug could widen options against resistant fungi.
Catalog record
| CREATOR | Yuting Wang, Bing Wang, Jinfeng Li, Shuqing Ma, Peng Liu, Zhitao Teng, Haijie Zou, Rinan Cong, Xiaojing Sui, Xiaohui Li, Yingjie Cui |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |